Case Report: Mitochondrial insufficiency underlies cholinergic failure in post-vaccination long COVID: a candidate treatment protocol - Takeaways - MDSpire

Clinical Case Study: Mitochondrial Dysfunction as a Cause of Cholinergic Impairment in Long COVID Post-Vaccination: Proposed Treatment Approach

  • By

  • Tom Goulding

  • July 21, 2026

Share

  • 1

    An 80-year-old male with severe long COVID experienced acute deterioration after COVID-19 vaccination despite ongoing cholinergic therapy.

  • 2

    A comprehensive mitochondrial support protocol was initiated, targeting NAD+ repletion and oxidative stress, delivered in fresh-squeezed orange juice.

  • 3

    Clinical response was dramatic within 48 hours, with sustained functional recovery over 6 weeks following the protocol.

  • 4

    Challenge-rechallenge testing revealed that citric acid from orange juice was essential for the protocol's efficacy, indicating substrate limitation.

  • 5

    This case suggests that cholinergic support may require concurrent metabolic foundation, with some long COVID manifestations potentially metabolically reversible.

Original Source(s)

Case Report: Mitochondrial insufficiency underlies cholinergic failure in post-vaccination long COVID: a candidate treatment protocol

  • by Tom Goulding

  • July 21, 2026

Related Content

Improving fidelity of implementation of self-administered pulse oximetry and remote patient monitoring in Honduras during the COVID-19 pandemic

Hybrid immunity from bivalent vaccination and prior infection enhances humoral and innate protection against Omicron XBB.1.16 and EG.5.1.1 variants in Japan

Can Consumer Wearables Support PASC Monitoring?

Heart rate monitoring and atrial fibrillation detection had the strongest supporting evidence, but investigators found limited evidence for broader outpatient self-monitoring applications.